TipRanks
JD Health International, Inc. (HK:6618)
:6618
Hong Kong Market
Want to see HK:6618 full AI Analyst Report?

JD Health International, Inc. (6618) Ratios

23 Followers

JD Health International, Inc. Ratios

HK:6618's free cash flow for Q2 2026 was ¥0.26. For the 2026 fiscal year, HK:6618's free cash flow was decreased by ¥ and operating cash flow was ¥0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.69 2.72 3.77 3.28 3.45
Quick Ratio
2.34 2.37 3.39 2.93 3.08
Cash Ratio
0.95 1.53 1.46 1.03 1.14
Solvency Ratio
0.29 0.26 0.27 0.16 0.03
Operating Cash Flow Ratio
0.39 0.48 0.28 0.32 0.36
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 35.39B¥ 34.85B¥ 42.43B¥ 32.93B¥ 39.95B
Leverage Ratios
Debt-to-Assets Ratio
0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.01 0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.37 1.36 1.29 1.30 1.37
Debt Service Coverage Ratio
254.83 307.72 82.40 250.90 -41.05
Interest Coverage Ratio
309.93 342.22 141.92 73.88 -15.95
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.28 0.20 0.08 0.07 0.07
Net Debt to EBITDA
-3.82 -7.64 -17.01 -5.06 303.92
Profitability Margins
Gross Profit Margin
25.29%24.78%22.88%22.17%21.16%
EBIT Margin
6.10%5.17%2.00%5.05%1.51%
EBITDA Margin
6.54%5.55%2.26%5.47%-0.13%
Operating Profit Margin
6.10%5.17%2.00%1.31%-0.31%
Pretax Profit Margin
9.38%8.21%8.25%5.03%1.49%
Net Profit Margin
7.86%7.32%7.16%4.00%0.81%
Continuous Operations Profit Margin
7.85%7.31%7.15%4.00%0.82%
Net Income Per EBT
83.83%89.14%86.77%79.52%54.63%
EBT Per EBIT
153.79%158.77%412.47%384.38%-479.47%
Return on Assets (ROA)
7.33%6.59%5.84%3.33%0.62%
Return on Equity (ROE)
10.15%8.94%7.54%4.34%0.85%
Return on Capital Employed (ROCE)
7.65%6.24%2.09%1.41%-0.32%
Return on Invested Capital (ROIC)
6.38%5.53%1.80%1.12%-0.18%
Return on Tangible Assets
7.49%6.75%6.02%3.45%0.64%
Earnings Yield
6.02%3.37%5.00%1.96%0.19%
Efficiency Ratios
Receivables Turnover
143.40 168.25 103.94 75.74 35.92
Payables Turnover
4.06 4.18 4.30 4.31 3.50
Inventory Turnover
7.94 7.58 7.68 8.19 6.14
Fixed Asset Turnover
52.41 59.67 72.39 185.87 185.53
Asset Turnover
0.93 0.90 0.82 0.83 0.76
Working Capital Turnover Ratio
2.18 1.87 1.53 1.46 1.20
Cash Conversion Cycle
-41.44 -36.98 -33.77 -35.27 -34.71
Days of Sales Outstanding
2.55 2.17 3.51 4.82 10.16
Days of Inventory Outstanding
45.96 48.17 47.55 44.54 59.40
Days of Payables Outstanding
89.94 87.32 84.82 84.63 104.28
Operating Cycle
48.50 50.34 51.06 49.36 69.56
Cash Flow Ratios
Operating Cash Flow Per Share
2.68 3.11 1.37 1.46 1.90
Free Cash Flow Per Share
2.61 3.05 1.36 1.44 1.89
CapEx Per Share
0.06 0.05 0.01 0.02 0.01
Free Cash Flow to Operating Cash Flow
0.97 0.98 0.99 0.98 0.99
Dividend Paid and CapEx Coverage Ratio
41.74 67.55 93.46 66.42 147.04
Capital Expenditure Coverage Ratio
41.74 67.55 93.46 66.42 147.04
Operating Cash Flow Coverage Ratio
9.75 15.62 16.77 21.44 29.61
Operating Cash Flow to Sales Ratio
0.11 0.14 0.07 0.09 0.13
Free Cash Flow Yield
8.07%6.12%5.15%4.16%3.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.80 29.67 19.99 50.90 514.97
Price-to-Sales (P/S) Ratio
1.31 2.17 1.43 2.04 4.19
Price-to-Book (P/B) Ratio
1.67 2.65 1.51 2.21 4.37
Price-to-Free Cash Flow (P/FCF) Ratio
12.39 16.34 19.41 24.04 33.37
Price-to-Operating Cash Flow Ratio
12.03 16.04 19.21 23.68 33.15
Price-to-Earnings Growth (PEG) Ratio
0.57 1.09 0.21 0.11 -3.83
Enterprise Value Multiple
16.25 31.43 46.27 32.15 -2.91K
Enterprise Value
83.36B 128.16B 60.84B 94.20B 177.23B
EV to EBITDA
16.25 31.43 46.27 32.15 -2.91K
EV to Sales
1.06 1.75 1.05 1.76 3.79
EV to Free Cash Flow
10.04 13.14 14.19 20.77 30.22
EV to Operating Cash Flow
9.78 12.90 14.04 20.46 30.01
Tangible Book Value Per Share
18.76 18.20 16.86 14.98 13.68
Shareholders’ Equity Per Share
19.34 18.80 17.52 15.67 14.41
Tax and Other Ratios
Effective Tax Rate
0.16 0.11 0.13 0.20 0.45
Revenue Per Share
24.70 22.98 18.45 16.99 15.04
Net Income Per Share
1.94 1.68 1.32 0.68 0.12
Tax Burden
0.84 0.89 0.87 0.80 0.55
Interest Burden
1.54 1.59 4.12 1.00 0.99
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
0.17 0.07 0.08 0.04 0.05
Stock-Based Compensation to Revenue
<0.01 <0.01 0.02 0.03 0.05
Income Quality
1.38 1.85 1.04 2.15 15.54
Currency in CNY